AwesomeCapital
Search This Blog
Friday, September 27, 2019
Mizuho Securities Starts Arcus Biosciences (RCUS) at Buy
Mizuho Securities analyst Mara Goldstein initiates coverage on Arcus Biosciences (NYSE: RCUS) with a Buy rating and a price target of $22.
https://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Starts+Arcus+Biosciences+%28RCUS%29+at+Buy/15953878.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.